| The euphoria, the warnings and the downfall of the current bioresorbale stents: could the journey be restarted? |
|
Kounis, Nicholas G.
(Department of Cardiology, University of Patras Medical School)
Koniari, Ioanna (Department of Cardiology, Royal Bromptom Hospital) Chourdakis, Emmanouil (Krankenhaus der Barmherzigen Bruder Trier) Velissaris, Dimitrios (Department of Internal Medicine, University of Patras Medical School) Hahalis, George (Department of Cardiology, University of Patras Medical School) |
| 1 | Kwon O, Ahn JM, Kang DY, et al. Early experience and favorable clinical outcomes of everolimus-eluting bioresorbable scaffolds for coronary artery disease in Korea. Korean J Intern Med 2018;33:922-932. DOI |
| 2 | Tamai H, Igaki K, Kyo E, et al. Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans. Circulation 2000;102:399-404. DOI |
| 3 | Ormiston JA, Serruys PW, Regar E, et al. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial. Lancet 2008;371:899-907. DOI |
| 4 | Onuma Y, Serruys PW, Ormiston JA, et al. Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB trial. EuroIntervention 2010;6:447-453. DOI |
| 5 | Onuma Y, Dudek D, Thuesen L, et al. Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial. JACC Cardiovasc Interv 2013;6:999-1009. DOI |
| 6 | Ho HH, Er Ching M, Ong PJ, Ooi YW. Subacute bioresorbable vascular scaffold thrombosis: a report of 2 cases. Heart Vessels 2015;30:545-548. DOI |
| 7 | Kounis NG, Soufras GD, Tsigkas G, Hahalis G. Bioabsorbable stent thrombosis Quo Vadis: is Kounis syndrome still present? Int J Cardiol 2014;176:305-306. DOI |
| 8 | Lendlein A, Langer R. Biodegradable, elastic shape-memory polymers for potential biomedical applications. Science 2002;296:1673-1676. DOI |
| 9 | Bostman O, Pihlajamaki H. Clinical biocompatibility of biodegradable orthopaedic implants for internal fixation: a review. Biomaterials 2000;21:2615-2621. DOI |
| 10 | Ji W, Yang F, Seyednejad H, et al. Biocompatibility and degradation characteristics of PLGA-based electrospun nanofibrous scaffolds with nanoapatite incorporation. Biomaterials 2012;33:6604-6614. DOI |
| 11 | Sorrentino S, Giustino G, Mehran R, et al. Everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents. J Am Coll Cardiol 2017;69:3055-3066. DOI |
| 12 | Kounis NG, Koniari I, Tsigkas G, Soufras GD, Hahalis G. Where are the secrets of increased thrombosis and aneurysm formation with the current bioresorbable vascular scaffolds hidden? Circ J 2018;82:608-609. DOI |
| 13 | Kounis NG, Koniari I, Davlouros P, Soufras G, Tsigkas G, Hahalis G. Bioresorbable stents: quo vantis? J Thorac Dis 2017;9:E1032-E1034. DOI |
| 14 | Wykrzykowska JJ, Kraak RP, Hofma SH, et al. Bioresorbable scaffolds versus metallic stents in routine PCI. N Engl J Med 2017;376:2319-2328. DOI |
| 15 | Ali ZA, Serruys PW, Kimura T, et al. 2-Year outcomes with the absorb bioresorbable scaffold for treatment of coronary artery disease: a systematic review and meta-analysis of seven randomised trials with an individual patient data substudy. Lancet 2017;390:760-772. DOI |
 |
Korea Institute of Science and Technology Information
Gwahangno, Yuseong-gu, Daejeon, 305-806, Korea TEL : +82-42-869-1752
Copyright (c) 2009 KISTI. All Rights Reserved. For more information mail to
webmaster
